| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.26 | 0.3 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.065 | 0.3 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.084 | 0.3 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.3 |